1 Helmholtz Zentrum München, Institute of Lung Biology and Disease, Group Systems Medicine of Chronic Lung Disease, Member of the German Center for Lung Research (DZL), Munich, Germany.
2 Harvard Stem Cell Institute, Cambridge, Massachusetts.
Am J Respir Cell Mol Biol. 2019 Jul;61(1):31-41. doi: 10.1165/rcmb.2018-0416TR.
Lung disease accounts for every sixth death globally. Profiling the molecular state of all lung cell types in health and disease is currently revolutionizing the identification of disease mechanisms and will aid the design of novel diagnostic and personalized therapeutic regimens. Recent progress in high-throughput techniques for single-cell genomic and transcriptomic analyses has opened up new possibilities to study individual cells within a tissue, classify these into cell types, and characterize variations in their molecular profiles as a function of genetics, environment, cell-cell interactions, developmental processes, aging, or disease. Integration of these cell state definitions with spatial information allows the in-depth molecular description of cellular neighborhoods and tissue microenvironments, including the tissue resident structural and immune cells, the tissue matrix, and the microbiome. The Human Cell Atlas consortium aims to characterize all cells in the healthy human body and has prioritized lung tissue as one of the flagship projects. Here, we present the rationale, the approach, and the expected impact of a Human Lung Cell Atlas.
肺部疾病是导致全球每六个人死亡的原因。目前,对健康和疾病状态下所有肺部细胞类型的分子状态进行分析,正在彻底改变对疾病机制的识别,并将有助于设计新的诊断和个性化治疗方案。单细胞基因组和转录组分析的高通量技术的最新进展为研究组织内的单个细胞、将这些细胞分类为细胞类型,并根据遗传学、环境、细胞间相互作用、发育过程、衰老或疾病等因素,对其分子特征的变化进行特征描述,开辟了新的可能性。将这些细胞状态定义与空间信息进行整合,可以深入描述细胞群落和组织微环境,包括组织驻留的结构和免疫细胞、组织基质和微生物组。人类细胞图谱协会的目标是对健康人体中的所有细胞进行特征描述,并将肺部组织作为旗舰项目之一。在这里,我们提出了人类肺部细胞图谱的基本原理、方法和预期影响。